Govt Tightens Cough Syrup Rules; Prescription Mandate Expands to More Formulations
India withdraws Schedule K exemption, requiring prescriptions for more cough syrup formulations including codeine-based variants. The move, triggered by safety concerns over India-made syrups linked to overseas deaths, hits OTC pharmacy retail volumes and reshapes counter-sales economics for chemists.
Government tightens cough syrup rules by withdrawing a Schedule K exemption, mandating prescriptions for more formulations including those with codeine. Move follows safety concerns over India-made syrups linked to overseas deaths; impacts pharmacy retail and OTC sales.